FDA

• Novavax expects to produce COVID-19 vaccine targeting Omicron by fall

  Novavax Inc NVAX.O said on Friday it expects to provide a COVID-19 vaccine targeting Omicron in the fourth quarter.

  Health

  Jul 1
  
• U.S. FDA backs COVID-19 booster shots tailored to target Omicron BA.4, BA.5 subvariants

  The BA.4 and BA.5 Omicron COVID-19 subvariants are now dominant in the United States, according to data from the Cenetrs for Disease Control and Prevention.

  Health

  Jun 30
  
• Advertisement
• FDA advisors meet to discuss future of COVID-19 vaccine design

  Outside advisers to the U.S. Food and Drug Administration are meeting on Tuesday to discuss whether to change the design of COVID-19 vaccines in order to combat future variants.

  World

  Jun 28
• Advertisement
• FDA investigating another infant death potentially related to Abbott baby formula

  The U.S. Food and Drug Administration (FDA) said on Wednesday it was notified of one more infant death in January potentially related to Abbott Laboratories' ABT.N baby formula.

  Health

  Jun 23
• U.S. FDA advisors endorse COVID-19 vaccines for kids under 5 years old

  If the FDA and CDC both give final approval to Pfizer and Moderna's shots, they could be available as soon as next week for the country's youngest children.

  Health

  Jun 15
• Patients with rare eye cancer travel cross-country for treatment: ‘This was traumatizing’

  Treatment for late-stage ocular melanoma is scarce but a new drug, being reviewed by Health Canada, has patients travelling great distances for a chance at survival. 

  Health

  Jun 14
• Canada becomes first country to approve experimental ALS drug treatment Albrioza

  Although Health Canada has approved the drug treatment Albrioza, the drug is still under the U.S.'s Food and Drug Administration review.

  Health

  Jun 13
• U.S. FDA warns against heart inflammation risk from Novavax COVID-19 vaccine

  The U.S. Food and Drug Administration has raised concerns about a possible risk of heart inflammation from Novavax Inc's NVAX.OCOVID-19 vaccine.

  Health

  Jun 3
• Advertisement
• Moderna says COVID-19 vaccine for kids under 6 will be ready for U.S. review in June

  Moderna's COVID-19 vaccine could be the first to win U.S. approval for children under the age of 5. Pfizer also expects to have its vaccine data for children under 6 ready soon.

  Health

  May 1
• Advertisement
• U.S. FDA issues plan to ban menthol cigarettes, flavoured cigars

  Menthol cigarettes, banned in many states including California and Massachusetts, account for more than a third of the industry's overall market share in the United States.

  Health

  Apr 28